Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells

[1]  Y. Ho,et al.  Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential. , 2014, Journal of agricultural and food chemistry.

[2]  Qi Xie,et al.  Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells , 2014, Genes, chromosomes & cancer.

[3]  K. Ayyanathan.  Potential Utility of Natural Products as Regulators of Breast Cancer-Associated Aromatase Promoters , 2014 .

[4]  Z. Ali,et al.  Characterization of Steroidal Saponins from Dioscorea villosa and D. cayenensis Using Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Quadrupole Time-of-Flight Mass Spectrometry , 2014, Planta Medica.

[5]  P. Smolewski,et al.  Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells. , 2014, European journal of pharmacology.

[6]  M. van den Berg,et al.  Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model. , 2013, Toxicology and applied pharmacology.

[7]  M. Kettler,et al.  Male breast disease: pictorial review with radiologic-pathologic correlation. , 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  Fan Shen,et al.  Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry. , 2013, Clinical chemistry.

[9]  Z. Ali,et al.  Cholestane steroid glycosides from the rhizomes of Dioscorea villosa (wild yam). , 2013, Carbohydrate research.

[10]  Z. Ling,et al.  Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation , 2013, Oncogene.

[11]  Z. Werb,et al.  GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression , 2013, Nature Cell Biology.

[12]  Y. Tamaki,et al.  Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  V. Stearns,et al.  Epigenetics as a Therapeutic Target in Breast Cancer , 2012, Journal of Mammary Gland Biology and Neoplasia.

[14]  H. Aburatani,et al.  Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation , 2012, Cancer science.

[15]  L. Walker,et al.  Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. , 2012, Chemical research in toxicology.

[16]  M. Balasubramanian,et al.  Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma. , 2012, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[17]  Peng Huang,et al.  Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. , 2011, Cancer research.

[18]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[19]  Yang Wang,et al.  Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.

[20]  Georgia Sotiropoulou,et al.  DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. , 2011, Clinical chemistry.

[21]  C. Iacobuzio-Donahue,et al.  Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers , 2011, Oncotarget.

[22]  P. Neven,et al.  BREAST CANCER PREVENTION: LIFESTYLE CHANGES AND CHEMOPREVENTION , 2011, Acta clinica Belgica.

[23]  L. Walker,et al.  Potential utility of natural products as regulators of breast cancer-associated aromatase promoters , 2011, Reproductive biology and endocrinology : RB&E.

[24]  Krishna R. Kalari,et al.  Integrated Analysis of Gene Expression, CpG Island Methylation, and Gene Copy Number in Breast Cancer Cells by Deep Sequencing , 2011, PloS one.

[25]  J. Medina-Franco,et al.  Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach , 2010, Molecular Diversity.

[26]  Steve Horvath,et al.  Higher levels of GATA3 predict better survival in women with breast cancer. , 2010, Human pathology.

[27]  Z. Ali,et al.  Teratogenic effects of blue cohosh (Caulophyllum thalictroides) in Japanese medaka (Oryzias latipes) are probably mediated through GATA2/EDN1 signaling pathway. , 2010, Chemical research in toxicology.

[28]  L. Kastl,et al.  Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. , 2010, International journal of oncology.

[29]  Stefano Amatori,et al.  DNA demethylating antineoplastic strategies: a comparative point of view. , 2010, Genes & cancer.

[30]  K. Bystricky,et al.  The Role of Histone Modifications and Variants in Regulating Gene Expression in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[31]  M. Esteller,et al.  Breast Cancer Epigenetics: From DNA Methylation to microRNAs , 2010, Journal of Mammary Gland Biology and Neoplasia.

[32]  D. Bell.  Our changing view of the genomic landscape of cancer , 2009, The Journal of pathology.

[33]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[34]  W. Grizzle,et al.  Biomarkers and the genetics of early neoplastic lesions. , 2010, Cancer biomarkers : section A of Disease markers.

[35]  J. Keen,et al.  The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines , 2010, Breast Cancer Research and Treatment.

[36]  Michele D. Sobolewski,et al.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells , 2010, Breast Cancer Research and Treatment.

[37]  R. Weigel,et al.  GATA-3 as a marker of hormone response in breast cancer. , 2009, The Journal of surgical research.

[38]  Manfred Schmitt,et al.  DNA methylation as a biomarker in breast cancer. , 2009, Future oncology.

[39]  W. Holzgreve,et al.  Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array , 2009, Oncogene.

[40]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[41]  N. Heintz,et al.  The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.

[42]  D. Newman,et al.  Nature: a vital source of leads for anticancer drug development , 2009, Phytochemistry Reviews.

[43]  W. Ahn,et al.  Estrogen activities and the cellular effects of natural progesterone from wild yam extract in mcf-7 human breast cancer cells. , 2009, The American journal of Chinese medicine.

[44]  T. Molinski,et al.  Drug development from marine natural products , 2009, Nature Reviews Drug Discovery.

[45]  I. Khan,et al.  Disruption of circulation by ethanol promotes fetal alcohol spectrum disorder (FASD) in medaka (Oryzias latipes) embryogenesis. , 2008, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[46]  Susan J. Clark,et al.  Breast cancer epigenetics: normal human mammary epithelial cells as a model system , 2008, Journal of Molecular Medicine.

[47]  A. Ganesan.  The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.

[48]  David J Newman,et al.  Natural products as leads to potential drugs: an old process or the new hope for drug discovery? , 2008, Journal of medicinal chemistry.

[49]  M. Esteller.  Epigenetics in cancer. , 2008, The New England journal of medicine.

[50]  M. Butler.  Natural products to drugs: natural product-derived compounds in clinical trials. , 2005, Natural product reports.

[51]  J. Keen,et al.  Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR , 2008, Breast Cancer Research and Treatment.

[52]  Jen-kun Lin,et al.  Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2‐overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation , 2007, FEBS letters.

[53]  R. Kiyama,et al.  Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[54]  W. Kitching,et al.  Complete 1H and 13C assignments of the four major saponins from Dioscorea villosa (wild yam) , 2007, Magnetic resonance in chemistry : MRC.

[55]  Kornelia Polyak,et al.  Breast cancer: origins and evolution. , 2007, The Journal of clinical investigation.

[56]  Akihiko Koga,et al.  Targeted reduction of the DNA methylation level with 5-azacytidine promotes excision of the medaka fish Tol2 transposable element. , 2006, Genetical research.

[57]  D. Carroll.  Nonhormonal therapies for hot flashes in menopause. , 2006, American family physician.

[58]  M. Lacaille‐Dubois,et al.  Steroidal saponins and flavan-3-ol glycosides from Dioscorea villosa , 2006 .

[59]  J. Peedicayil.  Epigenetic therapy--a new development in pharmacology. , 2006, The Indian journal of medical research.

[60]  B. Zhu,et al.  Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids , 2005, Molecular Pharmacology.

[61]  Dioscorea Villosa.  Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract. , 2004, International journal of toxicology.

[62]  Ni Ai,et al.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.

[63]  D. Tripathy,et al.  Traditional Chinese medicine in the treatment of breast cancer. , 2002, Seminars in oncology.

[64]  Martin Widschwendter,et al.  DNA methylation and breast carcinogenesis , 2002, Oncogene.

[65]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[66]  M. Esteller.  Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. , 2000, European journal of cancer.

[67]  T. Bestor,et al.  The DNA methyltransferases of mammals. , 2000, Human molecular genetics.

[68]  E. Oakeley.  DNA methylation analysis: a review of current methodologies. , 1999, Pharmacology & therapeutics.

[69]  B. Dutrillaux,et al.  DNA methylation and chromosome instability in breast cancer cell lines , 1999, FEBS Letters.

[70]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[71]  S. Baylin,et al.  Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2′deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells* , 1997, The Journal of Biological Chemistry.

[72]  Aradhana,et al.  Diosgenin--a growth stimulator of mammary gland of ovariectomized mouse. , 1992, Indian journal of experimental biology.

[73]  H. Pitot,et al.  Characterization of polyribosomes and maturation of ribosomal RNA in hepatoma cells treated with 5-azacytidine. , 1974, Cancer research.

[74]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .